BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8484185)

  • 1. 18-Substituted steroids. Part 18. Chemical synthesis and mineralocorticoid activity of 2 alpha- and 2 beta-hydroxyaldosterone.
    Kirk DN; Schröder MH; Latif SA; Souness GW; Morris DJ
    Steroids; 1993 Feb; 58(2):59-63. PubMed ID: 8484185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid activity of 19-hydroxyaldosterone, 19-nor-aldosterone, and 3 beta-hydroxy-delta 5-aldosterone: relative potencies measured in two bioassay systems.
    Morris DJ; Brem AS; Saccoccio NA; Pacholski M; Harnik M
    Endocrinology; 1986 Jun; 118(6):2505-9. PubMed ID: 3084221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18-Substituted steroids. Part 15. 6 beta-Hydroxylation of aldosterone by liver.
    Kirk DN; Burke PJ; Toms HC; Latif SA; Morris DJ
    Steroids; 1989 Aug; 54(2):169-84. PubMed ID: 2588296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible biological role of aldosterone metabolites.
    Morris DJ; Kenyon CJ; Latif SA; McDermott M; Goodfriend TL
    Hypertension; 1983; 5(2 Pt 2):I35-40. PubMed ID: 6826227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 19-hydroxyaldosterone and the 3 beta-hydroxy-5-ene analog of aldosterone, active mineralocorticoids.
    Harnik M; Kashman Y; Aharonowitz Y; Morris DJ
    J Steroid Biochem; 1985 Aug; 23(2):207-18. PubMed ID: 4033120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mineralocorticoids: 5alpha-dihydroaldosterone and 5alpha-dihydro-11-deoxycorticosterone.
    Sekihara H; Island DP; Liddle GW
    Endocrinology; 1978 Oct; 103(4):1450-2. PubMed ID: 744157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 19-noraldosterone, a potent mineralocorticoid.
    Harnik M; Kashman Y; Cojocaru M; Rosenthal T; Morris DJ
    J Steroid Biochem; 1986 Jun; 24(6):1163-9. PubMed ID: 3736043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid activity of reduced metabolites of aldosterone in rats [proceedings].
    Morris DJ; DeConti GA; Latif SA
    J Endocrinol; 1979 May; 81(2):111P-112P. PubMed ID: 458298
    [No Abstract]   [Full Text] [Related]  

  • 9. Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone.
    Kenyon CJ; Brem AS; McDermott MJ; Deconti GA; Latif SA; Morris DJ
    Endocrinology; 1983 May; 112(5):1852-6. PubMed ID: 6403339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 6-dehydro-DOCA and 6-dehydro-9 alpha-fluorocortisol acetate on the excretion of sodium and potassium in the rat.
    Genard P; Palem-Vliers M
    J Steroid Biochem; 1985 Nov; 23(5A):673-5. PubMed ID: 4079383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 6 beta-hydroxyaldosterone by A6 (toad kidney) cells in culture.
    Morris DJ; Latif SA; Conca TJ; Wei LT; Watlington CO; Kirk DN; Toms HC; Shackleton CH
    Steroids; 1990 Nov; 55(11):482-7. PubMed ID: 1963710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Other physiological considerations of protective mechanisms of mineralocorticoid action.
    Souness GW; Myles K; Morris DJ
    Steroids; 1994 Feb; 59(2):142-7. PubMed ID: 8191544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of aldosterone-induced antinatriuresis and kaliuresis by actinomycin D.
    Horisberger JD; Diezi J
    Am J Physiol; 1984 Feb; 246(2 Pt 2):F201-4. PubMed ID: 6696121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18-oxocortisol, a naturally occurring mineralocorticoid agonist.
    Ulick S; Land M; Chu MD
    Endocrinology; 1983 Dec; 113(6):2320-2. PubMed ID: 6641637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of infusions of ring-A-reduced derivatives of aldosterone on the antinatriuretic and kaliuretic actions of aldosterone.
    Morris DJ; Souness GW; Saccoccio NA; Harnik M
    Steroids; 1989; 53(1-2):21-36. PubMed ID: 2772968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnane.
    Ulick S; Marver D; Adam WR; Funder JW
    Endocrinology; 1979 May; 104(5):1352-6. PubMed ID: 436780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physiological response to aldosterone in adrenalectomized and intact rats and its sex dependence.
    Morris DJ; Berek JS; Davis RP
    Endocrinology; 1973 Apr; 92(4):989-93. PubMed ID: 4686328
    [No Abstract]   [Full Text] [Related]  

  • 19. Arterial levels and mineralocorticoid activity of 18-hydroxy-11-deoxycorticosterone in the rat.
    Nicholls MG; Brown WC; Hay GD; Mason PA; Fraser R
    J Steroid Biochem; 1979 Jan; 10(1):67-70. PubMed ID: 513718
    [No Abstract]   [Full Text] [Related]  

  • 20. Further studies of the mineralocorticoid activity of 19-oxo-deoxycorticosterone.
    Kenyon CJ; Saccoccio NA; Morris DJ
    Endocrinology; 1984 Aug; 115(2):535-7. PubMed ID: 6745168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.